Communications Biology (Jun 2022)

Serine hydroxymethyltransferase as a potential target of antibacterial agents acting synergistically with one-carbon metabolism-related inhibitors

  • Yuko Makino,
  • Chihiro Oe,
  • Kazuya Iwama,
  • Satoshi Suzuki,
  • Akie Nishiyama,
  • Kazuya Hasegawa,
  • Haruka Okuda,
  • Kazushige Hirata,
  • Mariko Ueno,
  • Kumi Kawaji,
  • Mina Sasano,
  • Emiko Usui,
  • Toshiaki Hosaka,
  • Yukako Yabuki,
  • Mikako Shirouzu,
  • Makoto Katsumi,
  • Kazutaka Murayama,
  • Hironori Hayashi,
  • Eiichi N. Kodama

DOI
https://doi.org/10.1038/s42003-022-03555-x
Journal volume & issue
Vol. 5, no. 1
pp. 1 – 12

Abstract

Read online

Structural and biophysical studies of the inhibition of bacterial serine hydroxymethyltransferase (SHMT) by a human SHMT inhibitor used for cancer therapy, (+)-SHIN-1, identify SHMT as a potent antibacterial target.